The pharmaceutical business is a critical component of the healthcare sector, responsible for drug research, development, manufacture, and distribution. It serves an important role in promoting and preserving public health by studying and developing drugs to prevent, treat, or cure numerous medical disorders.
Here are 3 pharma stocks with export contributions of up to 90 percent of total revenue.
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the manufacturing, developing, and marketing of a wide range of branded and generic formulations and active pharmaceutical ingredients (APIs).
With a market capitalization of Rs 4.45 lakh crore, the shares were closed at Rs 1,859 per share, decreased around 0.33 percent as compared to the previous year.
The company’s 69 percent revenue comes from out of India which stands at Rs 32,361 crore and the company’s 31 percent of its revenue comes from India which stands at Rs 15,396 crore.
Dr Reddys Laboratories Ltd
Dr. Reddy’s Laboratories Limited provides a diverse range of goods and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC). Its primary clinical areas of interest are gastrointestinal, cardiovascular, diabetology, cancer, pain management, and dermatology.
With a market capitalization of Rs 1.11 lakh crore, the shares were closed at Rs 6,661 per share, decreased around 0.34 percent as compared to the previous year.
The company’s 83 percent revenue comes from out of India which stands at Rs 23,069 crore and the company’s 17 percent of its revenue comes from India which stands at Rs 4,847.3 crore.
Aurobindo Pharma Ltd
Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals, and related services.
With a market capitalization of Rs 91,819 crore, the shares were closed at Rs 1,567 per share, increased around 0.44 percent as compared to the previous year.
The company’s 90 percent revenue comes from out of India which stands at Rs 9,245 crore and the company’s 10 percent of its revenue comes from India which stands at Rs 1,025 crore.
Written by:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
